Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®

PHASE3CompletedINTERVENTIONAL
Enrollment

1,137

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Tiotropium

marketed product

DRUG

Placebo matching Olodaterol

one dose

DRUG

Tiotropium

marketed product

DRUG

Olodaterol

one dose

Trial Locations (94)

Unknown

1222.52.02090 Boehringer Ingelheim Investigational Site, Anniston

1222.52.02046 Boehringer Ingelheim Investigational Site, Birmingham

1222.52.02014 Boehringer Ingelheim Investigational Site, Mobile

1222.52.02017 Boehringer Ingelheim Investigational Site, Montgomery

1222.52.02092 Boehringer Ingelheim Investigational Site, Anchorage

1222.52.02072 Boehringer Ingelheim Investigational Site, Chandler

1222.52.02063 Boehringer Ingelheim Investigational Site, Glendale

1222.52.02088 Boehringer Ingelheim Investigational Site, Peoria

1222.52.02012 Boehringer Ingelheim Investigational Site, Phoenix

1222.52.02006 Boehringer Ingelheim Investigational Site, Huntington Beach

1222.52.02031 Boehringer Ingelheim Investigational Site, San Jose

1222.52.02011 Boehringer Ingelheim Investigational Site, Torrance

1222.52.02061 Boehringer Ingelheim Investigational Site, Boulder

1222.52.02054 Boehringer Ingelheim Investigational Site, Fort Collins

1222.52.02001 Boehringer Ingelheim Investigational Site, Hartford

1222.52.02037 Boehringer Ingelheim Investigational Site, Norwalk

1222.52.02055 Boehringer Ingelheim Investigational Site, Waterbury

1222.52.02094 Boehringer Ingelheim Investigational Site, Clearwater

1222.52.02022 Boehringer Ingelheim Investigational Site, Fort Lauderdale

1222.52.02074 Boehringer Ingelheim Investigational Site, Orlando

1222.52.02016 Boehringer Ingelheim Investigational Site, Ponte Verda

1222.52.02084 Boehringer Ingelheim Investigational Site, Saint Petersberg

1222.52.02043 Boehringer Ingelheim Investigational Site, Tampa

1222.52.02009 Boehringer Ingelheim Investigational Site, Blue Ridge

1222.52.02048 Boehringer Ingelheim Investigational Site, Duluth

1222.52.02077 Boehringer Ingelheim Investigational Site, Gainsville

1222.52.02040 Boehringer Ingelheim Investigational Site, Rincon

1222.52.02024 Boehringer Ingelheim Investigational Site, O'Fallon

1222.52.02002 Boehringer Ingelheim Investigational Site, Muncie

1222.52.02008 Boehringer Ingelheim Investigational Site, Fort Mitchell

1222.52.02025 Boehringer Ingelheim Investigational Site, Louisville

1222.52.02089 Boehringer Ingelheim Investigational Site, New Orleans

1222.52.02005 Boehringer Ingelheim Investigational Site, Baltimore

1222.52.02029 Boehringer Ingelheim Investigational Site, Columbia

1222.52.02036 Boehringer Ingelheim Investigational Site, Hollywood

1222.52.02015 Boehringer Ingelheim Investigational Site, Townson

1222.52.02034 Boehringer Ingelheim Investigational Site, North Dartmouth

1222.52.02003 Boehringer Ingelheim Investigational Site, Chelsea

1222.52.02020 Boehringer Ingelheim Investigational Site, Kalamazoo

1222.52.02047 Boehringer Ingelheim Investigational Site, Minneapolis

1222.52.02049 Boehringer Ingelheim Investigational Site, Minneapolis

1222.52.02079 Boehringer Ingelheim Investigational Site, Plymouth

1222.52.02068 Boehringer Ingelheim Investigational Site, Chesterfield

1222.52.02028 Boehringer Ingelheim Investigational Site, St Louis

1222.52.02053 Boehringer Ingelheim Investigational Site, St Louis

1222.52.02050 Boehringer Ingelheim Investigational Site, Billings

1222.52.02035 Boehringer Ingelheim Investigational Site, Henderson

1222.52.02030 Boehringer Ingelheim Investigational Site, Marlton

1222.52.02071 Boehringer Ingelheim Investigational Site, Albuquerque

1222.52.02064 Boehringer Ingelheim Investigational Site, Johnson City

1222.52.02087 Boehringer Ingelheim Investigational Site, New Windsor

1222.52.02091 Boehringer Ingelheim Investigational Site, Syracuse

1222.52.02076 Boehringer Ingelheim Investigational Site, Calabash

1222.52.02010 Boehringer Ingelheim Investigational Site, Huntersville

1222.52.02045 Boehringer Ingelheim Investigational Site, Raleigh

1222.52.02038 Boehringer Ingelheim Investigational Site, Salisbury

1222.52.02051 Boehringer Ingelheim Investigational Site, Shelby

1222.52.02058 Boehringer Ingelheim Investigational Site, Tabor City

1222.52.02013 Boehringer Ingelheim Investigational Site, Winston-Salem

1222.52.02062 Boehringer Ingelheim Investigational Site, Cincinnati

1222.52.02039 Boehringer Ingelheim Investigational Site, Columbus

1222.52.02081 Boehringer Ingelheim Investigational Site, Columbus

1222.52.02093 Boehringer Ingelheim Investigational Site, Columbus

1222.52.02059 Boehringer Ingelheim Investigational Site, Oklahoma City

1222.52.02026 Boehringer Ingelheim Investigational Site, Medford

1222.52.02097 Boehringer Ingelheim Investigational Site, Medford

1222.52.02075 Boehringer Ingelheim Investigational Site, Philadelphia

1222.52.02102 Boehringer Ingelheim Investigational Site, Philadelphia

1222.52.02080 Boehringer Ingelheim Investigational Site, Pittsburgh

1222.52.02100 Boehringer Ingelheim Investigational Site, Charleston

1222.52.02096 Boehringer Ingelheim Investigational Site, Easley

1222.52.02085 Boehringer Ingelheim Investigational Site, Greenville

1222.52.02101 Boehringer Ingelheim Investigational Site, Greenville

1222.52.02065 Boehringer Ingelheim Investigational Site, Hodges

1222.52.02042 Boehringer Ingelheim Investigational Site, Myrtle Beach

1222.52.02083 Boehringer Ingelheim Investigational Site, Rock Hill

1222.52.02066 Boehringer Ingelheim Investigational Site, Spartanburg

1222.52.02095 Boehringer Ingelheim Investigational Site, Spartanburg

1222.52.02098 Boehringer Ingelheim Investigational Site, Union

1222.52.02018 Boehringer Ingelheim Investigational Site, Brentwood

1222.52.02086 Boehringer Ingelheim Investigational Site, Arlington

1222.52.02044 Boehringer Ingelheim Investigational Site, Austin

1222.52.02041 Boehringer Ingelheim Investigational Site, El Paso

1222.52.02027 Boehringer Ingelheim Investigational Site, Fort Worth

1222.52.02056 Boehringer Ingelheim Investigational Site, Houston

1222.52.02007 Boehringer Ingelheim Investigational Site, San Antonio

1222.52.02060 Boehringer Ingelheim Investigational Site, San Antonio

1222.52.02078 Boehringer Ingelheim Investigational Site, Sugar Land

1222.52.02082 Boehringer Ingelheim Investigational Site, Waco

1222.52.02057 Boehringer Ingelheim Investigational Site, Midvale

1222.52.02023 Boehringer Ingelheim Investigational Site, Richmond

1222.52.02069 Boehringer Ingelheim Investigational Site, Selah

1222.52.02019 Boehringer Ingelheim Investigational Site, Tacoma

1222.52.02099 Boehringer Ingelheim Investigational Site, Morgantown

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY